Ipamorelin
Description
Ipamorelin is a synthetic pentapeptide that acts as a potent and selective growth hormone secretagogue (GHS). Unlike other GH-releasing peptides such as GHRP-2 and GHRP-6, Ipamorelin demonstrates remarkable selectivity—it stimulates growth hormone release from the pituitary gland without causing significant increases in cortisol, prolactin, or appetite-stimulating hormones like ghrelin. This selectivity profile makes it one of the cleanest GH secretagogues available for research purposes. Developed initially by Novo Nordisk and later studied by various research groups, Ipamorelin binds to the ghrelin receptor (GHS-R1a) and triggers pulsatile GH release that closely mimics the body's natural secretion patterns. Research has demonstrated its potential applications in muscle development, fat metabolism, bone density, and recovery enhancement.
Certificate of Analysis
Every batch of Ipamorelin is independently lab-tested to a minimum of 98% purity. A Certificate of Analysis is available on request — contact us with your order or lot number and we'll send the COA for your specific batch.
Request a COAResearch Protocol
Full dose-by-dose reconstitution & dosing protocol for Ipamorelin.
View Research Protocol →Research protocol for this size is coming soon.
For laboratory and scientific research use only. Not medical advice.
For laboratory and research use only. Minimum 98% purity. Supplied in sterile, flip-top headspace vials for laboratory use. Not intended for human or animal consumption, medical, diagnostic, therapeutic or veterinary use. These statements have not been evaluated by the MHRA or FDA. The purchaser accepts full responsibility for safe handling, storage and lawful use.